Registrant : Organisation or self-employed individual
| Name/company name: |
Teva Pharmaceuticals Europe BV |
| Acronym: |
Teva
|
| Legal status: |
BV
|
| Website address: |
http://www.tevapharm.com
|
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
Rob Koremans
|
| Position: |
President and CEO, Teva Pharmaceuticals Europe BV |
Permanent person in charge of EU relations
| Surname, Name: |
Mr
Marcel Daniëls
|
| Position: |
Vice-President European Government Relations |
Contact details:
| Contact details of organisation's head office: |
10 Computerweg
Utrecht 3542 DR
NETHERLANDS
|
| Telephone number: |
(+31346) 290200 |
| Fax number: |
(+31346) 290289 |
| Other contact information: |
Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 47,000 employees worldwide, of which more than 14,000 in the European Union.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
Teva's European Headquarters are in Utrecht, the Netherlands.
Its Brussels office is at : Belfortstraat 43, 1000 Brussels. Tel nr 02.734.44.02.
|
Goals / remit
| Goals / remit of the organisation: |
Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 47,000 employees worldwide, of which more than 14,000 in the European Union.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
1
|
|
Complementary information:
|
|
Persons accredited for access to European Parliament premises
| First name
|
Surname
|
Start Date |
End Date |
|
Marcel
|
DANIËLS
|
28/11/12
|
19/11/13
|
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
Health and Consumer Affairs
Pharmaceutical legislation (Pharmaceutical Package, Falsified Medicines Directive, Transparency Directive)
Trade agreements
Competition (mergers and acquisition)
EU Patent and Patent Court
Access to Medicines
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Competition
- Consumer Affairs
- Customs
- Economic and Financial Affairs
- Enlargement
- Enterprise
- External Relations
- Humanitarian Aid
- Information Society
- Internal Market
- Justice and Fundamental Rights
- Public Health
- Research and Technology
- Trade
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
European Generic Medicines Association
Friends of Europe
|
Financial data
| Financial year: |
12/2011
-
11/2012
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
100000
€ - 150000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
|
|
